Publications by authors named "Pablo M Rey"

Claim this Profile
B
Beyond the status quo: when disease volume and metastatic timing are not enough to personalize treatment in mHSPC.
Ángel Borque-Fernando, Teresa Alonso-Gordoa, María José Juan-Fita, Fernando Lopez Campos, Daniel Adolfo Pérez-Fentes, Pablo Maroto Rey

Future Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1.
Neeraj Agarwal, Daniel Castellano, Teresa Alonso-Gordoa, Jose Angel Arranz Arija, Emeline Colomba, Loic Mourey, Pablo M Rey

Clin Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.
Magnus Lindskog, Anna Laurell, Anders Kjellman, Bohuslav Melichar, Pablo Maroto Rey

Eur Urol Open Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Ra-dichloride in castration-resistant prostate cancer with bone metastasis: A case report.
Montserrat Estorch Cabrera, Pablo Maroto Rey, Ignasi Carrió, Alberto Montes, Diego Alonso López

Oncol Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib: tolerance in patients on chronic hemodialysis: a single-center experience.
Pablo Maroto Rey, Humberto Villavicencio

Oncology· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis